BMS-986263
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BMS-986263, covering 2022-02-04 to 2024-09-04. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH) [Phase 2]